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Abstract: Background and purpose: Carotid Angioplasty and Stenting (CAS) has emerged as an alternative to Carotid 
Endarterectomy (CEA) in treatment of carotid stenotic disease. With increasing life expectancy clinicians are more often 
confronted with patients of higher age. Octogenarians were often excluded from randomized trials comparing CAS to 
CEA because they were considered high-risk for revascularization. Conflicting results on the peri-procedural outcome of 
carotid revascularization in these patients have been reported. In order to objectively evaluate whether age above 80 years 
should be an upper limit for indicating carotid revascularization we systematically reviewed the currently available litera-
ture.  
Methods: Literature was systematically reviewed between January 2000 and June 2010 using Pubmed and Embase, to 
identify all relevant studies concerning CAS and CEA in octogenarians. Inclusion criteria were 1) reporting outcome on 
either CEA or CAS; and 2) data subanalysis on treatment outcome by age. The 30-day Major Adverse Event (MAE) rate 
(disabling stroke, myocardial infarction or death) was extracted as well as demographic features of included patients. 
Results: After exclusion of 23 articles, 46 studies were included in this review, 18 involving CAS and 28 involving CEA. 
A total of 2.963 CAS patients and 14.365 CEA patients with an age >80 years were reviewed. The MAE rate was 6.9% 
(range 1.6 - 24.0%) following CAS and 4.2% (range 0 – 8.8%) following CEA.  
A separate analysis in this review included the results of one major registry 140.376 patients) analyzing CEA in octoge-
narians only reporting on 30-day mortality and not on neurological or cardiac adverse events. When these data were in-
cluded the MAE following CEA is 2.4% (range 0 – 8.8%) 
Conclusions: MAE rates after CEA in octogenarians are comparable with the results of large randomized trials in younger 
patients. Higher complication rates are described for CAS in octogenarians. In general, age > 80 years is not an absolute 
cut off point to exclude patients from carotid surgery. In our opinion, CEA should remain the golden standard in the 
treatment of significant carotid artery stenoses, even in the very elderly. 
Keywords: Carotid revascularization, angioplasty, stenting, octogenarians, demographic features, revascularization. 
INTRODUCTION 
  Carotid Angioplasty and Stenting (CAS) has emerged as 
an alternative to Carotid Endarterectomy (CEA) for the 
treatment of carotid artery stenoses in the prevention of 
stroke 
1. Recent results of large randomized trials have 
shown that CAS however has a higher peri-procedural com-
plication rate compared to CEA [2-4]. The authors concluded 
that CAS should only be considered in high-risk patients not 
suitable for surgery and that CEA remains the gold standard 
until long-term results of randomized trials can be reported.  
  The question remains which patients should be consid-
ered as high-risk patients. Previous neck surgery, prior neck 
cancer with radiation therapy, clinical significant cardiopul-
monary disease or an age above 80 have been exclusion 
criteria in many large carotid trials that were conducted to 
evaluate the durability of CEA for the prevention of stroke 
[5-9]. Age has also been identified as an independent predic-
tor of complications in carotid interventions [10-12]. Mean 
life expectancy has steadily increased over time, and elderly 
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people have become the fastest growing population segment 
in industrialized countries. Hence, elderly people are typi-
cally seen in everyday clinical practice and will become an 
increasingly important group of patients in the future. “High-
risk” patients were often offered the endovascular alternative 
to surgical treatment because CAS is considered to be a less 
invasive revascularization option. Some authors state that 
CAS can be performed safely in high-risk patients [13-15], 
but subgroups often are too small to draw any conclusions on 
the procedural risk of for example patients of higher age. 
Octogenarians however, were excluded from most trials 
evaluating CAS. To date, there has not been a randomized 
trial comparing CAS with CEA in octogenarians.  
  In order to answer two specific questions; 1) is carotid 
revascularization in octogenarians safe to perform; and 2) is 
CAS compared to CEA a safer treatment option for octoge-
narians in terms of perioperative MAE; we systematically 
reviewed current literature on carotid revascularization in 
octogenarians.  
METHODS 
  Literature was searched to identify all relevant studies on 
carotid revascularization in octogenarians. The search was 
restricted to papers published between January 2000 and 16 Current Cardiology Reviews, 2011, Vol. 7, No. 1  Reichmann et al. 
June 2010. Studies were initially identified from the Med-
line/Pubmed database, EMBASE and the Cochrane database 
using the search terms “carotid stenosis”, “carotid an-
gioplasty”, “carotid stenting”, “carotid revascularization”, 
“carotid endarterectomy”, “octogenarians” and “(very) eld-
erly”. 
  Studies were included if they reported on octogenarians 
treated by CAS or CEA. Results of major adverse events 
(MAE) (disabling stroke, myocardial infarction or death) had 
to be described in order to be included. Studies however 
were excluded if: 1) The age of the patient population was 
<80 years, 2) review articles or letters did not describe rates 
of major adverse events, 3) articles were written in non-
English language . The reference list of the included articles 
was also screened for additional studies concerning our sub-
ject. Data on 30-day MAE rates as well demographic fea-
tures of the included patients were extracted from the articles 
and analyzed.  
RESULTS 
Search Results 
  Sixty-nine studies were initially identified with our 
search strategy (Fig. 1; flow chart). Of these 69 initial arti-
cles, 10 articles did not meet our inclusion criteria, 2 were 
case reports, 4 articles were written in non-English languages 
and 4 articles lacked description of Major Adverse Event 
(MAE). Six articles were excluded because there was a lack 
of demographic data on included patients and 7 articles de-
scribed carotid revascularization in a patient population with 
an average age <80 years. After exclusion 46 articles met our 
inclusion criteria (18 CAS and 28 CEA) [16-60].  
Carotid Angioplasty and Stenting in Octogenarians 
  The combined amount of CAS procedures performed in 
the included articles was 10.896. Of these procedures 2.837 
were performed in octogenarians. Demographic features and 
an outline of included articles are shown in Table 1. Forty-
nine percent of patients treated by CAS were symptomatic. 
In two series, a significant higher complication rate was 
observed in symptomatic octogenarians compared to asymp-
tomatic octogenarians [21, 24].  
  Other series included in this review did not analyze the 
difference between symptomatic and asymptomatic octoge-
narians. An Embolic Protection Device (EPD) was used in 
86% of the patients. Usman et al who conducted a meta-
analysis on carotid revascularization in octogenarians de-
scribe a review of 826 patients 
19. They concluded that octo-
genarians undergoing CAS have a 3.46-times higher absolute 
risk of stroke than those undergoing CEA, with no signifi-
cant difference in mortality and a trend toward a lower rate 
of myocardial infarction. The rate of MAE (disabling stroke, 
myocardial infarction or death) varied from 1,6 to 24%. The 
total number of MAE was 206 which corresponds to a com-
bined MAE rate of 6,9% in the 2.837 included patients. 
These MAE’s were mainly stroke related; myocardial infarc-
tion was relatively rare following CAS. Zahn et al reported 
only non-fatal strokes and death and did not analyze cardiac 
complications 
24. Their MAE rate of 5,5% is therefore 
probably underestimated.  
Fig. (1). Flow chart of search results. Is Age of 80 Years a Threshold for Carotid Revascularization?  Current Cardiology Reviews, 2011, Vol. 7, No. 1    17
  An age > 80 years is as an independent risk factor for 
peri-procedural MAE [25, 27, 31], and thus age over 80 was 
an exclusion criterium in many carotid trials. This policy 
however was not endorsed by the results of other authors in 
this review. They did not observe significant increases in 
complication rates of octogenarians compared to younger 
patients.  
  The use of an EPD is essential in the prevention of peri-
procedural cerebrovascular events according to three authors, 
because of the observed higher event rate compared to un-
protected CAS procedures [23, 24, 26].  
Carotid Endarterectomy in Octogenarians 
  Much more data are available on CEA in octogenarians. 
The included articles and their demographic features are 
outlined in Table 2. The by far largest cohort was reported 
by Lichtman et al. who analyzed data of all 140.376 patients 
older than 80 years undergoing CEA in the United States 
during a period of 6 years (1993-1999) [33]. They collected 
data on patients from their medical records. Their group 
reported a 30-day mortality rate of 2,2% but did not specify 
the cause of death nor did they report on cerebrovascular 
complication rates. Ninety-three of the total included patients 
in this review are coming from their patient population. If 
this group is included the combined MAE rate would be 
2,4%. This however considerably underestimates the exact 
MAE rates because of the lack of figures about neurological 
and cardiac complications.  
  When the study of Lichtman is not included, a patient 
population of 60.060 containing 14.365 octogenarians re-
mains for analysis. In total 47% of the included patients 
undergoing CEA were symptomatic. The MAE rates in the 
included articles varied between 0-8,3%. The total number of 
MAE was 606 on a total of 14.365 CEA’s in patients older 
than 80. The combined MAE rate was 4.2%. Two authors 
describe that especially symptomatic octogenarians are more 
at risk for peri-procedural complications compared to asymp-
tomatic patients undergoing CEA [39, 59].  
DISCUSSION 
  With the increasing life expectancy clinicians are more 
often confronted with elderly patients affected by carotid 
obstructive disease. It has been estimated that 30-40% of 
strokes in octogenarians are secondary to stenotic or occlu-
sive disease of the carotid bifurcation [61]. Carotid revascu-
larization in the elderly remains controversial and conflicting 
Table 1.  Carotid Angioplasty and Stenting (CAS) Study Collection and 30-day MAE Rates. 
First author  Year Total CAS  Octogenarians, N Male Mean age Symptomatic EPD used Nr of MAE's MAE (%)
Micari [16]  2010  198  198  68%  83.2  39%  100%  5  2.5% 
Grant [17]  2010  418  418  63%  83.2  32%  79%  14  3.3% 
Bacharach [18]  2010  235  78  72%  83.5  20%  99%  7  9.0% 
Usman* [19]  2009  826  826  NR  82.2  65%  100%  84  9.9% 
Linfante [20]  2009  178  24  67%  82.4  71%  100%  2  8.4% 
Cremonesi [21]  2009  1.523  237  72%  NR  24%  88%  5  2.1% 
Jackson [22]  2008  215  35  53%  NR  41%  92%  4  11.4% 
Henry [23]  2008  930  121  72%  82.0  64%  95%  2  1.6% 
Velez [60]  2008  816  126  56%  82.9  40%  50%  3  2.7% 
Zahn** [24]  2007  2.878  321  65%  82.5  61%  68%  18  5.5% 
Lam  [25]  2007  135  37  65%  85.0 100% 99%  4  10.8% 
Villalobos  [26]  2006  75  75 55%  83.1 56%  54%  18 24.0% 
Stanziale [27]  2006  382  87  83%  83.0  18%  62%  8  9.2% 
Setacci [28]  2006  1.222  144  75%  82.0  65%  92%  5  3.5% 
Longo [29]  2005  158  29  74%  82.3  17%  89%  1  3.4% 
Hobson  [30]  2004  749  99 64%  NR 30%  100% 12 12.1% 
Roubin  [31]  2001  604  66 67%  NR 52%  100% 11 16.0% 
Shawl [32]  2000  170  42  59%  NR  61%  0%  1  2.9% 
Total     11.712  2.963  67%  82.9  49%  86%  203  6.9% 
* Meta-analysis of CAS vs. CEA in octogenarians 
** All non-fatal strokes and death 
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results on peri-procedural outcome have been reported. Two 
studies however, have shown that, on average, 80% of octo-
genarians survive at least 4 years after endarterectomy and 
that the vast majority is stroke free at 5 to 10 years follow-up 
[58, 62]. Norman et al conclude that the likelihood of living 
long enough to gain benefit from a carotid endarterectomy is 
not jeopardized by being too old [49]. Elderly patients with a 
symptomatic carotid stenosis treated by best medical treat-
ment have the highest risk on future cerebrovascular events 
[63]. It might therefore be beneficial to offer any carotid 
revascularization, whether surgical or endovascular, to octo-
genarians to decrease this relatively high risk of (recurrent) 
stroke.  
Table 2.  Carotid Endarterectomy (CEA) Study Collection and 30-day MAE Rates. 
First author  Year  Total CEA  Octogenarians, N  Male   Mean age, y Symptomatic Nr of MAE's MAE (%)
Lichtman [33]  2010  140.376  140.376  NR  83.0  NR  3.088  2.2% 
Usman* [19]  2009  7.017  7.017  NR  82.7  54%  316  4.5% 
Halm  [34]  2009  9.308  2.198 NR  NR NR 106  4.8% 
Bremner [35]  2008  195  105  62%  83.7  43%  6  5.7% 
Ballotta [36]  2006  1.260  112  62%  84.2  66%  1  0.9% 
Teso [37]  2005  14.679  2.379  54%  NR  11%  100  4.2% 
Pulli [38]  2005 1.883  149  70% NR  NR  1  0.6% 
Miller [39]  2005 2.217  360  NR 83.6  59%  15  4.2% 
Lau [40]  2005  286  33  100%  82.0  51%  3  8.0% 
Grego [41]  2005  1.733  125  66%  NR  50%  1  0.8% 
Durward [42]  2005  1.800  26  NR  91.3  81%  0  0.0% 
Varghese [43]  2004  359  33  61%  NR  76%  3  8.8% 
Hingorani [44]  2004  565  299  51%  NR  43%  8  2.7% 
Ballotta [45]  2004  1.150  92  52%  83.7  66%  0  0.0% 
Witz [46]  2003  360  47  66%  82.0  51%  4  8.3% 
Rockman [47]  2003  698  161  52%  NR  46%  4  2.5% 
Pruner [48]  2003  3.430  269  62%  82.9  83%  8  3.1% 
Norman [49]  2003  2.023  151  67%  NR  NR  4  2.6% 
Salameh [50]  2002  293  42  NR  NR  NR  2  4.8% 
Ozsvath [52]  2002  3.932  125  45%  83.0  50%  3  2.4% 
Metz [53]  2002  32  32  50%  82.0  100%  1  3.2% 
Cartier [54]  2002  475  65  51%  82.6  76%  2  2.8% 
Saha [51]  2002  101  101  NR  86.5  71%  3  3.0% 
Ommer [55]  2001  2.262  70  63%  82.9  74%  3  4.2% 
Lepore [56]  2001  366  42  63%  82.8  40%  1  2.4% 
Ting [57]  2000  656  57  58%  82.0  86%  4  6.8% 
Schneider [58]  2000  582  88  61%  83.2  75%  1  1.1% 
Maxwell [59]  2000  2.398  187  47%  83.0  65%  8  4.1% 
Total incl. Lichtman et al    200.436 154.741  NR  83.5 47%  3.695  2.4% 
Total excl. Lichtman et al 60.060  14.365  NR  83.5  NR  606  4.2% 
* 30-day Mortality rates, stroke not analysed 
** Meta-analysis of CAS vs. CEA in octogenarians 
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  The result of this systematic review shows that octoge-
narians have an increased risk of major adverse events dur-
ing CAS compared to CEA. A recent meta-analysis concern-
ing carotid revascularization in octogenarians showed that 
the peri-procedural all-stroke rate was significantly higher 
during CAS [19]. The absolute risk on stroke was 3.46-times 
higher compared to patients undergoing CEA. There was 
also a trend towards higher mortality and myocardial infarc-
tion rates but these results did not reach statistical signifi-
cance. Several other authors like the CREST investigators 
endorse the conclusion of this meta-analysis. After interim 
analysis of the results of the lead-in phase of the CREST trial 
the inclusion of octogenarians was stopped. Octogenarians 
showed a 30-day stroke/death rate of 12.1% compared to 
3.2% in younger patients [30].  
  Other authors invalidate inferiority of CAS in octoge-
narians and showed excellent results in their patient popula-
tions [16, 18, 20, 28]. A recent meta-analysis by Bonati et al.
containing the pooled data of three recent large randomized 
trials confirmed the significant higher complication rates 
following CAS in patients > 75 years [64]  
  The explanation for this increase in major adverse events 
after CAS compared to CEA is poorly defined. Anatomic 
characteristics might play an important role in the occurrence 
of major adverse events. Octogenarians have an increased 
incidence of complex anatomic risk factors compared to 
younger patients [25, 65]. Lam et al have described several 
of these characteristics. They concluded that octogenarians 
have an increased incidence of unfavorable arch elongation, 
arch calcification, common carotid or innominate artery 
origin stenosis, common carotid artery tortuosity, and inter-
nal carotid artery tortuosity. Increased arch calcium content 
and type II aortic arches may be markers of increased poten-
tial for embolization during endovascular manipulation that 
transverses the aortic arch [66]. The rate of embolic events 
during CAS is considered to decrease when an embolic pro-
tection device (EPD) is used but preliminary manipulation of 
interventional devices through a calcified aortic arch might 
already have contributed to cerebral lesions, prior to EPD 
placement. The discussion on the standard use of CPD not 
closed; also in the light of recent findings that new cerebral 
infarctions were higher in CAS than in CEA, especially in 
CPD assisted CAS [67]. Kastrup et al also described the 
correlation between the incidence of new lesions on diffu-
sion–weighted imaging and aortic arch calcification in the 
elderly [68]. 
  Another explanation might be found in plaque character-
istics at the target site. There are no data available in the 
current literature reporting on specific carotid plaque charac-
teristics in octogenarians, but plaque stability has been re-
ported to decrease with age [69]. It might be conceivable that 
the underlying plaque composition in octogenarians is more 
unstable and rupture prone, compared to carotid plaques in 
younger patients, which might contribute to the increased 
risk for thrombo-embolic events during CAS, due to plaque 
disruption initiated by endovascular devices and stents. Our 
study group is currently conducting a study concerning 
plaque stability in octogenarians compared to younger pa-
tients, but results have to be awaited. 
  Embolization is not uncommon during CAS. The use of 
EPD might prevent some events but the embolization can 
occur during each step of the procedure. A lot of these mi-
cro-emboli occur subclinically but some factors could pro-
voke subclinical events and lesions to become clinical. One 
of these factors is cerebral reserve but data concerning the 
effect of cerebral reserve on outcome of carotid revasculari-
zation is poorly defined in octogenarians. Chaer et al studied 
cerebral reserve and saw that an age >/=70 is associated with 
poor cerebral reserve in patients with significant carotid 
stenosis as measured by Cerebral Blood Flow response to an 
acetazolamide challenge [70]. This poor reserve might make 
older patients more sensitive to micro-emboli and therefore 
explain the higher risk of stroke during CAS compared to 
CEA.  
  Interventionalists often attribute higher rates of major 
adverse events during CAS in large randomized trials to the 
fact that less experienced interventionalists are compared to 
experienced surgeons. Experienced interventionalists are 
more likely to recognize treacherous anatomy and make 
adjustments to minimize procedural risks than less experi-
enced operators. Patient selection and a well considered 
choice for an either surgical or endovascular approach re-
mains a key factor in carotid revascularization. Some authors 
therefore believe that when appropriate patient selection and 
evaluation of their preoperative risk factors is performed 
equal peri-procedural results can be achieved in CAS and 
CEA in high risk patients 
71 So far, however, the data derived 
in this review concluded otherwise. 
  Whether or not a patient is symptomatic could attribute to 
the risk of major adverse events. A carotid artery stent regis-
try noted a significant difference in stroke rates in sympto-
matic octogenarians of 7.1% versus 3.9% in younger symp-
tomatic patients. This relevant difference was not found in 
asymptomatic patients (3.4% vs. 2.6%). Other authors, in-
cluding the CREST investigators, did not find an increased 
peri-procedural complication rate between symptomatic and 
asymptomatic octogenarians [30] 
  The data obtained in this review show a 30-day MAE rate 
of 4.2% following CEA in octogenarians. This MAE rates 
are consistent with complication rates of recent large ran-
domized trials in non-octogenarians [2-4]. It seems a consis-
tent finding that CEA can be safely performed in the very 
elderly with equal complication rates compared to a younger 
population.  
  This review is limited by the age cut-off point. On pur-
pose, we focused on octogenarians (age > 80 years) whereas 
some authors use an age > 75 years to define elderly in their 
studies. Our main focus was on octogenarians and therefore 
we had to discard and exclude 7 articles from our review. 
CONCLUSION 
  Age is not a criterion to withhold patients from surgery. 
CEA in both symptomatic and asymptomatic octogenarians 
can be performed with comparable and acceptable peri-
procedural complication rates as in younger patients. Higher 
complication rates in patients older than 80 years occur with 
CAS. Therefore, CEA must remain the gold standard in the 20    Current Cardiology Reviews, 2011, Vol. 7, No. 1  Reichmann et al. 
treatment of carotid occlusive disease, also in patients above 
the age of 80. 
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